WELLAGE POST PROCEDURE- glycerin cream

WELLAGE POST PROCEDURE by

Drug Labeling and Warnings

WELLAGE POST PROCEDURE by is a Otc medication manufactured, distributed, or labeled by HUGEL PHARMA CO.,LTD., Hanacos Co., Ltd.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

glycerin

INACTIVE INGREDIENT

water, cyclopentasiloxane, zinc oxide, titanium dioxide, arbutin, dimethicone, talc, sodium chloride, etc

PURPOSE

anti wrinkle
whitening
sun block

KEEP OUT OF REACH OF CHILDREN

keep out or reach of the children

INDICATIONS & USAGE

ake a proper amount and apply on the face evenly

WARNINGS

Do not use in the following cases(Eczema and scalp wounds)
Due to the use of this druf if rash, irritation, itching and symptopms of hypersnesitivity occur dicontinue use and consult ypur phamacisr or doctor
If in contact with the eyes, wash out thoroughty with water If the symptoms are servere, seek medical advice immediately
This product is for exeternal use only. Do not use for internal use
Storage and handling precautions
If possible, avoid direct sunlight and store in cool and area of low humidity
In order to maintain the quality of the product and avoid misuse
Avoid placing the product near fire and store out in reach of children

DOSAGE & ADMINISTRATION

for external use only

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

WELLAGE POST PROCEDURE 
glycerin cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 69346-1001
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)	GLYCERIN	5 g  in 100 mL

Inactive Ingredients
Ingredient Name	Strength
CYCLOMETHICONE 5 (UNII: 0THT5PCI0R)
DIMETHICONE (UNII: 92RU3N3Y1O)
ADENOSINE (UNII: K72T3FS567)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 69346-1001-1	40 mL in 1 BOTTLE

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part347	11/01/2014

Labeler - HUGEL PHARMA CO.,LTD. (688400184)

Registrant - HUGEL PHARMA CO.,LTD. (688400184)

Establishment
Name	Address	ID/FEI	Business Operations
Hanacos Co., Ltd.		690177857	manufacture(69346-1001)